Clinical trial
Clinical Trial in Patients With Metastatic Colorectal Cancer
NCT00081627 · Mast Therapeutics, Inc., Industry · Completed
Key facts
| NCT number | NCT00081627 |
|---|---|
| Title | Clinical Trial in Patients With Metastatic Colorectal Cancer |
| Official title | COFU: A Multi-Center Phase II Clinical Trial to Evaluate the Safety and Efficacy of Weekly Treatment With CoFactor and 5-Fluorouracil in Patients With Metastatic Colorectal Carcinoma |
| Lead sponsor | Mast Therapeutics, Inc., Industry |
| Collaborators | University of California, San Diego |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colon Cancer, Rectal Cancer |
| Intervention type | Drug |
| Interventions | CoFactor and 5FU |
| Enrollment | 48 |
| Start date | Apr 1, 2004 |
| Completion | Jan 1, 2007 |
| First posted | Oct 14, 2004 |
| Last update posted | Nov 27, 2007 |
| Countries | Serbia and Montenegro, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: